Börse:

AVACTA GROUP PLC LS-,10

[WKN: A2ADP0 | ISIN: GB00BYYW9G87]

0,810€ -1,82%

Echtzeit-Aktienkurs AVACTA GROUP PLC LS-,10

Bid: Ask:

Nachrichten zur AVACTA GROUP PLC LS-,10 Aktie

» Nachrichtenticker öffnen

Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer

LONDON and PHILADELPHIA, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, the "Company", "Avacta"), a life…

Avacta Group Plc (AVCTF) Q4 2025 Earnings Call Transcript

…

Avacta raises £10 million in oversubscribed placing to advance cancer drug pipeline

Avacta Group has raised £10 million through an oversubscribed placing and subscription, issuing 15.87 million new shares at 63p each,…

Avacta Group Plc (AVCTF) Discusses Initial Faridoxorubicin Phase Ib Data and Safety Profile in Salivary Gland Cancer Transcript

…

Avacta Group Plc (AVCTF) Q2 2025 Earnings Call Transcript

…

Avacta Group raises £3.25 million through share placing By Investing.com

Avacta Group raises £3.25 million through share placing…

Avacta Group Plc (AVCTF) Preliminary Q4 2024 Earnings Conference Call Transcript

…

Avacta appoints Chief Scientific Officer

Dr. Michelle Morrow has been appointed as Chief Scientific Officer of Avacta Group plc, effective November 4, 2024. With nearly…

Avacta Group – Exploring NASDAQ Dual-Listing And Divesting Its Diagnostics Division, Analyst Has 188p Valuation, Shares Now 45.5p

On Wednesday 30th October, Avacta Group (LON:AVCT), the cancer treatments and diagnostics life sciences business, will be presenting a live…

Avacta Group Plc (AVCTF) Q2 2024 Earnings Call Transcript

…

Avacta Group elects to settle convertible bond payment in cash

Avacta Group has announced its decision to settle the upcoming July quarterly amortisation payment for its unsecured convertible bonds in…

Avacta Group PLC (AVCTF) Q4 2023 Earnings Call Transcript

…

‹
1
›